Major topic of respiratory medicine

Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I now have a solid picture of what both major pulmonology textbooks cover. Let me compile the full overview from this database content plus my medical knowledge.

Major Topics in Respiratory Medicine - Quick Overview

Based on Murray & Nadel's Textbook of Respiratory Medicine and Fishman's Pulmonary Diseases and Disorders (two of the most authoritative pulmonology references), here are the major topics:

1. Anatomy & Physiology of the Respiratory System

  • Airways: trachea, bronchi, bronchioles, alveoli
  • Pulmonary circulation vs. bronchial circulation
  • Lung volumes: TLC, FRC, RV, VC, FEV1, FVC
  • Gas exchange: V/Q matching, diffusion, dead space
  • Mechanics: compliance, airway resistance, work of breathing
  • Respiratory muscles: diaphragm, intercostals, accessory muscles
  • Control of breathing: central (medullary), peripheral chemoreceptors

2. Obstructive Lung Diseases

Asthma

  • Chronic airway inflammation with reversible bronchoconstriction
  • Triggers: allergens, exercise, cold air, infections
  • Pathology: eosinophilic inflammation, smooth muscle hypertrophy, mucus plugging
  • Diagnosis: spirometry (FEV1/FVC < 0.70, reversibility >12% with bronchodilator)
  • Management: stepwise - SABA, ICS, ICS+LABA, biologics (anti-IL-5, anti-IgE)

COPD

  • Predominantly caused by smoking; irreversible airflow limitation
  • Subtypes: chronic bronchitis (productive cough >3 months x 2 years) and emphysema (alveolar destruction)
  • Spirometric diagnosis: post-bronchodilator FEV1/FVC < 0.70
  • GOLD staging (I-IV) by FEV1% predicted
  • Management: smoking cessation, SABA/LAMA/LABA, ICS (in frequent exacerbators), pulmonary rehab, oxygen therapy, lung volume reduction

Bronchiectasis

  • Permanent abnormal bronchial dilatation from repeated infection/inflammation
  • Causes: post-infectious, cystic fibrosis, primary ciliary dyskinesia, immune deficiency
  • Feature: daily productive cough, recurrent exacerbations
  • CT chest: classic "signet ring" sign

3. Respiratory Infections

Pneumonia

  • Community-acquired (CAP): Streptococcus pneumoniae (most common), atypicals (Mycoplasma, Legionella, Chlamydia)
  • Hospital-acquired (HAP/VAP): gram-negatives (Pseudomonas, Klebsiella), MRSA
  • Severity scoring: CURB-65 (Confusion, Urea >7, RR ≥30, BP <90/60, age ≥65)
  • CXR: lobar consolidation (typical), bilateral patchy infiltrates (atypical/viral)

Tuberculosis (TB)

  • Mycobacterium tuberculosis; spread by aerosol
  • Primary vs. reactivation TB; miliary TB
  • Diagnosis: Mantoux test, IGRA, sputum AFB smear/culture, GeneXpert
  • Treatment: RIPE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) x 2 months, then RI x 4 months

COVID-19 / Viral pneumonitis

  • SARS-CoV-2, cytokine storm, organizing pneumonia pattern on CT

4. Pulmonary Vascular Disease

Pulmonary Embolism (PE)

  • Deep vein thrombosis -> embolism to pulmonary arteries
  • Risk: Virchow's triad (stasis, hypercoagulability, endothelial injury)
  • Presentation: pleuritic chest pain, dyspnea, hemoptysis, hypoxia
  • Wells score for pre-test probability; D-dimer; CTPA (gold standard)
  • Management: anticoagulation (LMWH/DOACs), thrombolysis for massive PE

Pulmonary Hypertension (PH)

  • mPAP >20 mmHg at rest
  • Groups 1-5 (WHO classification): PAH, left heart disease, lung disease, CTEPH, miscellaneous
  • Group 1 (PAH): idiopathic, heritable, drug-induced
  • Treatments: PDE-5 inhibitors (sildenafil), endothelin antagonists (bosentan), prostacyclins

5. Interstitial Lung Diseases (ILD)

  • Heterogeneous group of diffuse parenchymal lung diseases
  • Key patterns on HRCT: UIP, NSIP, DIP, COP, AIP
  • Idiopathic Pulmonary Fibrosis (IPF): most common ILD; UIP pattern; anti-fibrotics (nintedanib, pirfenidone)
  • Sarcoidosis: non-caseating granulomas; bilateral hilar lymphadenopathy; lung, skin, eye involvement
  • Hypersensitivity Pneumonitis: antigen-driven; farmer's lung, bird fancier's lung
  • Connective tissue disease-ILD: RA, SSc, SLE, polymyositis
  • Restrictive pattern on PFTs: reduced TLC, FVC, with normal FEV1/FVC

6. Lung Cancer

  • Leading cause of cancer death worldwide
  • Types:
    • Non-Small Cell (NSCLC, 85%): Adenocarcinoma (most common, peripheral), Squamous cell (central, cavitating), Large cell
    • Small Cell (SCLC, 15%): central, rapid growth, early metastasis, paraneoplastic syndromes (SIADH, Cushing's, Lambert-Eaton)
  • Risk factors: smoking (most important), radon, asbestos, occupational exposures
  • Staging: TNM for NSCLC; limited vs. extensive for SCLC
  • Diagnostics: CT chest, PET scan, bronchoscopy + biopsy, EBUS
  • Treatment: surgery (early NSCLC), chemo-radiation, targeted therapy (EGFR, ALK, ROS1 mutations), immunotherapy (PD-L1/PD-1 inhibitors)
  • Paraneoplastic syndromes: hypertrophic pulmonary osteoarthropathy, digital clubbing, SIADH

7. Pleural Diseases

Pleural Effusion

  • Transudate (Light's criteria: protein <0.5 ratio, LDH <0.6 ratio): heart failure, cirrhosis, nephrotic syndrome
  • Exudate: pneumonia (parapneumonic), malignancy, TB, PE
  • Diagnosis: thoracocentesis; pleural fluid analysis (pH, glucose, LDH, protein, cytology, culture)

Pneumothorax

  • Primary spontaneous (tall, thin young males), Secondary (COPD, CF, Marfan's)
  • Tension pneumothorax: medical emergency - tracheal deviation, absent breath sounds, hypotension
  • Management: aspiration, chest drain, pleurodesis for recurrent cases

Mesothelioma

  • Malignant pleural tumor; strongly linked to asbestos exposure
  • Long latency (20-40 years); poor prognosis

8. Respiratory Failure

TypePaO2PaCO2MechanismExamples
Type 1 (Hypoxic)LowNormal/LowV/Q mismatch, shunt, diffusionPneumonia, PE, ARDS, pulmonary oedema
Type 2 (Hypercapnic)LowHighHypoventilationCOPD exacerbation, neuromuscular disease, obesity hypoventilation

ARDS (Acute Respiratory Distress Syndrome)

  • Berlin definition: acute onset, bilateral infiltrates, PaO2/FiO2 <300, not cardiac
  • Management: low tidal volume ventilation (6 ml/kg IBW), prone positioning, conservative fluids

9. Sleep-Related Breathing Disorders

  • Obstructive Sleep Apnoea (OSA): repetitive upper airway collapse during sleep
    • Risk: obesity, retrognathia, large neck
    • Diagnosis: polysomnography (AHI ≥5)
    • Treatment: weight loss, CPAP (first-line), mandibular advancement device
  • Central Sleep Apnoea: lack of respiratory drive (Cheyne-Stokes in heart failure)

10. Occupational & Environmental Lung Diseases

  • Pneumoconioses: dust inhalation
    • Silicosis (silica), Asbestosis (asbestos), Coal worker's pneumoconiosis
  • Asthma: occupational triggers (isocyanates, latex, flour)
  • COPD: biomass fuel smoke, occupational dusts

11. Pulmonary Function Tests (PFTs) - Key Concepts

PatternFEV1FVCFEV1/FVCTLC
ObstructiveLowNormal/Low<0.70Normal/High
RestrictiveLowLowNormal/HighLow
MixedLowLow<0.70Low
  • Spirometry, Diffusion capacity (DLCO), Plethysmography, 6-minute walk test

12. Key Investigations in Respiratory Medicine

TestUse
CXRFirst-line; consolidation, effusion, pneumothorax
HRCT chestILD, bronchiectasis, PE
CTPAPulmonary embolism (gold standard)
Spirometry/PFTsObstructive vs. restrictive
ABGRespiratory failure, acid-base
BronchoscopyBAL, biopsy, airway visualization
EBUSMediastinal lymph node sampling
V/Q scanPE (if CTPA contraindicated)
Sputum AFBTB diagnosis
ThoracocentesisPleural effusion analysis

13. Respiratory Emergencies

  • Acute severe asthma / Status asthmaticus
  • Tension pneumothorax
  • Massive pulmonary embolism
  • ARDS
  • Acute exacerbation of COPD (AECOPD)
  • Haemoptysis (massive)

Sources: Murray & Nadel's Textbook of Respiratory Medicine (2-Volume) and Fishman's Pulmonary Diseases and Disorders (2-Volume Set) - both available in the medical library.
This overview covers the major clinical and pathophysiological domains you'll encounter in respiratory medicine, whether for clinical practice, postgraduate exams, or general study. Let me know which topic you want to go deeper on!
This is a shared conversation. Sign in to Orris to start your own chat.